Depuy Synthes Receives Fda Clearance For Teligen System Spinal News Raynham, mass. october 20, 2022 today, johnson & johnson medtech* announced that depuy synthes, the orthopaedics company of johnson & johnson**, has secured 510 (k) clearance from the u.s. food and drug administration (fda) for its teligen™ system, an integrated technology platform that enables minimally invasive surgical transforaminal. 31st october 2022. 6927. teligen system tower (depuy synthes) depuy synthes, the orthopaedics company of johnson & johnson, has secured 510 (k) clearance from the us food and drug administration (fda) for its teligen system, an integrated technology platform that enables minimally invasive surgical transforaminal lumbar interbody fusion (mis.
Depuy Synthes Receives Fda Clearance For Teligenв ў System October 24, 2022. johnson & johnson subsidiary depuy synthes has received fda clearance for its teligen system for minimally invasive surgical transforaminal lumbar interbody fusion (tlif) procedures using digital visualization. the system is comprised of a tower that includes a camera control system, a procedure kit with a disposable high. October 20, 2022 by danielle kirsh. johnson & johnson medtech’s depuy synthes this week announced it received fda 510 (k) clearance for its teligen technology platform for spinal procedures. Raynham, mass., oct. 20, 2022 prnewswire today, johnson & johnson medtech* announced that depuy synthes, the orthopaedics company of johnson & johnson**, has secured 510 (k) clearance from. Depuy synthes receives fda clearance for teligen™ system. new medtech advancement brings first of its kind technology to spine surgeons, delivering advanced visualization and user centric.
Spine Depuy Synthes Raynham, mass., oct. 20, 2022 prnewswire today, johnson & johnson medtech* announced that depuy synthes, the orthopaedics company of johnson & johnson**, has secured 510 (k) clearance from. Depuy synthes receives fda clearance for teligen™ system. new medtech advancement brings first of its kind technology to spine surgeons, delivering advanced visualization and user centric. Depuy synthes received fda 510(k) clearance for its minimally invasive spine platform, teligen, the devicemaker said oct. 20. teligen was cleared for minimally invasive transforaminal lumbar interbody fusion, according to a news release. The us food and drug administration (fda) has granted 510 (k) clearance for depuy synthes ’ teligen system, a combined technology platform. using digital tools for access and view, teligen facilitates less invasive surgical transforaminal lumbar interbody fusion (mis tlif) procedures. the system includes a tower that offers various.
юааdepuyюаб J J тащs юааteligenюаб юааsystemюаб юааreceivesюаб The Us юааfdaюаб Approval For User Depuy synthes received fda 510(k) clearance for its minimally invasive spine platform, teligen, the devicemaker said oct. 20. teligen was cleared for minimally invasive transforaminal lumbar interbody fusion, according to a news release. The us food and drug administration (fda) has granted 510 (k) clearance for depuy synthes ’ teligen system, a combined technology platform. using digital tools for access and view, teligen facilitates less invasive surgical transforaminal lumbar interbody fusion (mis tlif) procedures. the system includes a tower that offers various.
Comments are closed.